Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2025PharmaceuticsOpen Access

Nanocarriers Containing Curcumin and Derivatives for Arthritis Treatment: Mapping the Evidence in a Scoping Review

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBunzo SatoSCSusan Iida ChongNSNathalia Marçallo Peixoto Souza

Discussion

Loading...

Member takes

Overview

Scoping review maps curcumin's anti-inflammatory effects in arthritis, highlighting nanocarriers' potential benefits in enhancing bioavailability and efficacy.

Key Points

  • Curcumin's antioxidant and anti-inflammatory effects show promise for managing arthritis through nanocarrier systems.
  • Thirty-four studies analyzed reveal nanoparticles and nanoemulsions improve curcumin's solubility and bioavailability.
  • Most formulations were liquid and administered via intra-articular injection in animal models.
  • Findings indicate curcumin in nanocarriers outperforms free curcumin, yet human evidence remains limited.

Cite This Study

Sato et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d1958https://doi.org/10.3390/pharmaceutics17081022
View Full Paper
Ask AI
Bookmark
Share